From promise to people.

At Lineage, our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions

Genentech and Lineage are working together to expand benefits of cell therapy to eye diseases

We’re teaming up to create allogeneic retinal pigment epithelial (RPE) cells to either replace or support cells that are dysfunctional or absent due to degenerative disease

In May 2024, we announced a new services agreement with Genentech

Additional clinical, technical, training and manufacturing services to further support the ongoing advancement and optimization of the OpRegen® program